Viewpoints
Gut Microbiota
Potential for a Unifying Hypothesis for Prevention and Treatment of Hypertension
YanFei Qi, Seungbum Kim, Elaine M. Richards, Mohan K. Raizada, Carl J. Pepine
https://doi.org/10.1161/CIRCRESAHA.117.310734
Circulation Research. 2017;120:1724-1726
Originally published May 25, 2017YanFei Qi
From the Division of Cardiovascular Medicine, Department of Medicine (Y.Q., C.J.P.) and Department of Physiology and Functional Genomics (S.K., E.M.R., M.K.R.), College of Medicine, University of Florida, Gainesville.
Seungbum Kim
From the Division of Cardiovascular Medicine, Department of Medicine (Y.Q., C.J.P.) and Department of Physiology and Functional Genomics (S.K., E.M.R., M.K.R.), College of Medicine, University of Florida, Gainesville.
Elaine M. Richards
From the Division of Cardiovascular Medicine, Department of Medicine (Y.Q., C.J.P.) and Department of Physiology and Functional Genomics (S.K., E.M.R., M.K.R.), College of Medicine, University of Florida, Gainesville.
Mohan K. Raizada
From the Division of Cardiovascular Medicine, Department of Medicine (Y.Q., C.J.P.) and Department of Physiology and Functional Genomics (S.K., E.M.R., M.K.R.), College of Medicine, University of Florida, Gainesville.
Carl J. Pepine
From the Division of Cardiovascular Medicine, Department of Medicine (Y.Q., C.J.P.) and Department of Physiology and Functional Genomics (S.K., E.M.R., M.K.R.), College of Medicine, University of Florida, Gainesville.
Jump to
- Article
- Are HTN or RH Associated With a Unique Gut Microbial Signature?
- Could Gut Microbiota Act as a Vector to Transmit HTN Phenotype Among Family Members?
- Could Bidirectional Influences Between Gut Microbiota and Antihypertensive Medications Contribute to Development and Progression of RH?
- Pre- and Probiotics as Possible Antihypertensive Agents
- Knowledge Gaps and Recommendations to Address These Knowledge Gaps
- Sources of Funding
- Disclosures
- Footnotes
- References
- Info & Metrics
- eLetters

Article Information
vol. 120 no. 11 1724-1726
PubMed:
Published By:
Print ISSN:
Online ISSN:
History:
- Originally published May 25, 2017.
Copyright & Usage:
© 2017 American Heart Association, Inc.
Author Information
- YanFei Qi,
- Seungbum Kim,
- Elaine M. Richards,
- Mohan K. Raizada,
- Carl J. Pepine
- From the Division of Cardiovascular Medicine, Department of Medicine (Y.Q., C.J.P.) and Department of Physiology and Functional Genomics (S.K., E.M.R., M.K.R.), College of Medicine, University of Florida, Gainesville.
- Correspondence to Carl J. Pepine, MD, MACC, PO Box 100288, Gainesville, FL 32610. E-mail carl.pepine{at}medicine.ufl.edu; or Mohan K. Raizada, PO Box 100274, Gainesville, FL, 32610. E-mail mraizada{at}ufl.edu
Statistics from Altmetric.com
Article usage
This Issue
Jump to
- Article
- Are HTN or RH Associated With a Unique Gut Microbial Signature?
- Could Gut Microbiota Act as a Vector to Transmit HTN Phenotype Among Family Members?
- Could Bidirectional Influences Between Gut Microbiota and Antihypertensive Medications Contribute to Development and Progression of RH?
- Pre- and Probiotics as Possible Antihypertensive Agents
- Knowledge Gaps and Recommendations to Address These Knowledge Gaps
- Sources of Funding
- Disclosures
- Footnotes
- References
- Info & Metrics
Article Tools
- Gut MicrobiotaYanFei Qi, Seungbum Kim, Elaine M. Richards, Mohan K. Raizada and Carl J. PepineCirculation Research. 2017;120:1724-1726, originally published May 25, 2017https://doi.org/10.1161/CIRCRESAHA.117.310734
Citation Manager Formats